Arbutus Biopharma Corporation - Common Stock (ABUS)
ABUS did not make Shishin's board on 2026-09-01: below the liquidity floor (under about $20M traded/day). This is a mechanical screen result, not a view on the company. The figures below are research data, the mechanical screen result and the momentum, trend, and volatility indicators the engines observe, not investment advice.
Shishin's live daily signals are published each morning on the rankings board.
ABUS did not make Shishin's board on 2026-09-01: below the liquidity floor (under about $20M traded/day). This is a mechanical screen result, not a view on the company.
Is ABUS a Shishin signal?
On 2026-09-01, ABUS is not in Shishin's board. Below the liquidity floor (under about $20M traded/day). This is a mechanical screen result, not a recommendation.
What is ABUS's Shishin momentum score?
As of 2026-09-01, ABUS's composite momentum score is 53/100, a weighted blend of momentum, trend, and volatility indicators on a 0 to 100 scale.
Why didn't ABUS make the board?
Below the liquidity floor (under about $20M traded/day). Shishin's board takes only the names that clear its liquidity, trend, and score thresholds for the active market regime.
Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.